France Medical Devices Mice Market Insight
Published: 01 August 2026 | Report Format: Electronic (PDF) | Author: Komal and Radhika
France medical devices mice market is expected to experience an increase at a rate of 6.42% owing to high adoption rates of genetically engineered mouse models, increased need for pre-clinical medical device testing, growth in investment for oncology and neuroscience research, and expansion in translational biomedical studies.
France Medical Devices Mice Market Insights Forecasts to 2035
- The France Medical Devices Mice Market Size Was Estimated USD 142.8 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 6.42% from 2025 to 2035
- The France Medical Devices Mice Market Size is Expected to rise around USD 266.1 Million by 2035
Notable Insights for the France Medical Devices Mice Market
- The product-based segmentation indicates that the Genetically Engineered & Inbred Mouse Models segment holds a commanding position with almost 54% market share in the France Medical Devices Mice Market in 2025 due to its growing usage in medical device biocompatibility testing, implant research, and targeted therapy validation.
- The application-based segmentation shows that the Medical Device Efficacy, Surgical Device Testing & Translational Oncology segment dominates with a market share of almost 58% in the France Medical Devices Mice Market in 2025 as a result of increased use of precise animal modeling techniques and pre-clinical device safety protocols.
- The global revenue for Charles River Laboratories International, Inc. in fiscal year 2025 was estimated at about $4.12 billion, driven by rising demand for research animal models, pre-clinical safety assessment, and medical technology testing services.
- As per expectations, rising non-invasive imaging integration trends and micro-implant monitoring advancements along with ethical research standardization needs will drive market expansion in which humanized mouse models increase pre-clinical device trial predictability up to 41% and reduce experimental variance up to 31%.
Download the eBook (ToC)
Research Methodologies Used to Analyze the France Medical Devices Mice Market
The France medical devices mice market is analyzed by a blend of primary and secondary research approaches for ensuring accurate information about the market and its forecasted performance. Primary research is conducted through discussions with laboratory animal suppliers, contract research organizations (CROs), medical device research laboratories, academic medical centers, and biotechnology experts to analyze demand trends, technological progress, and competitive activities. Secondary research will involve analyzing reports published by research institutes and regulatory agencies, animal science journals, scientific papers, trade data, and industry organizations in connection with laboratory animal resources and pre-clinical device evaluation. Market estimation, trend analysis, and forecasting methods will be used for estimating market size, growth opportunities, price dynamics, and investments.
Decisions Advisors Research Methodology: Trusted Insights for Strategic Decision-Making
What is Decisions Advisors Research?
Decisions Advisors research delivers comprehensive market intelligence through detailed industry analysis, competitive benchmarking, trend forecasting, and data-driven business insights. Our research methodology combines advanced analytical frameworks with extensive primary and secondary research to help organizations make informed and strategic business decisions.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the France Medical Devices Mice Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in France Medical Devices Mice Market
- Charles River Laboratories International, Inc.
- Janvier Labs
- Taconic Biosciences, Inc.
- The Jackson Laboratory
- Inotiv, Inc. (Envigo)
- genOway S.A.
- CIPHE (Centre d'Immunophénomique)
- Transcure Bioservices
- Cyagen Biosciences
- Ozgene Pty Ltd
Recent Developments:
- In January 2026, Charles River Laboratories International, Inc. launched next-generation micro-chipped mouse models integrated with automated telemetry for real-time physiological monitoring during pre-clinical medical device trials.
- In October 2025, genOway S.A. entered into a strategic partnership with a leading European medical research institute to develop advanced humanized mouse models specifically tailored for testing bio-implantable devices and immunomodulatory tech.
Market Segmentation:
France Medical Devices Mice Market, By Type
- Genetically Engineered Mouse Models (GEMM)
- Inbred Mouse Strains
- Outbred Mouse Strains
- Hybrid & Mutant Mouse Models
- Immunodeficient & Humanized Mouse Models
France Medical Devices Mice Market, By Technology
- CRISPR-Cas9 Gene Editing Technologies
- Micro-Implant In-Vivo Telemetry
- In-Vivo Optical & Micro-CT Imaging
- Microfluidic & Surgical Implantation Platforms
- Cryopreservation & Colony Management Systems
France Medical Devices Mice Market, By Application
- Medical Device Biocompatibility & Safety Testing
- Surgical Device & Implant Testing
- Cardiovascular & Neuro-Device Evaluation
- Oncology & Drug-Device Combination Research
- Tissue Engineering & Regenerative Medicine Studies
Expert Views:
The growth of medical devices mice markets in France will be facilitated by increased use of genetically engineered mouse models, increasing number of pre-clinical medical device evaluation projects, and higher demand for humanized animal research tools. The use of CRISPR gene editing, micro-implant in-vivo telemetry, and non-invasive micro-CT imaging will contribute to improved efficiency in pre-clinical studies and enhanced demand in medical device biocompatibility testing, surgical implant research, cardiovascular device evaluation, oncology studies, and regenerative medicine research markets in France.
Author: Komal and Radhika By Decisions Advisors and Consulting